rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
227	Cholecystolithiasis	C0947622	15	86	6.53280762819e-11	4.579382691143837e-05	PTGS2,PPARG,UGT1A6,UGT1A1,APOA4,APOC1,FABP6,UGT1A,TP53,SLCO1A2,APOA1,APOC3,ABCC3,APOE,TTR
228	Cholelithiasis	C0008350	19	171	8.39717184675e-11	4.599556183175307e-05	PTGS2,PPARG,UGT1A6,UGT1A1,APOA4,APOC1,FABP6,UGT1A,TP53,SLCO1A2,UGT1A8,APOA1,APOC3,UGT1A7,ABCC3,APOE,UGT1A10,UGT1A9,TTR
230	Acute kidney injury	C0022660	22	270	1.82696302531e-10	4.639903167238249e-05	PTGS2,PPARG,CST3,UGT1A1,CFH,SLC22A8,TP53,ABCB1,HP,HDAC3,CYP2C19,CYP2C9,ALB,APOE,PPARA,ANXA1,SAA1,FN1,UGT1A9,SLC22A6,CFB,ATM
231	Hyperlipidemia, combined, 1	C0020473	21	293	2.00504091108e-09	4.66007665926972e-05	F7,CDCP1,PPARG,PTGS1,APOA4,APOC1,SLC25A13,ABCB1,APOC2,HP,NPHS1,APOA1,CYP2C19,APOC3,SLC10A1,CYP2C9,ALB,APOE,PPARA,SAA1,APOA2
232	Adverse drug events and drug allergies	C0041755	10	60	2.34717356662e-09	4.68025015130119e-05	PTGS2,UGT1A1,TP53,ABCB1,ABCC1,CYP2C9,ABCC4,ABCC2,ALB,PPARA
233	Drug-Induced Liver Injury	C0860207	17	198	3.00968960865e-09	4.700423643332661e-05	PTGS2,PPARG,UGT1A1,CES1,MED1,ABCB1,APOA1,CYP2C19,HPX,CYP2C9,ABCC2,ALB,APOE,PPARA,UGT1A9,GSN,TTR
234	Kidney Failure, Chronic	C0022661	31	616	4.69314742624e-09	4.720597135364132e-05	PTGS2,F7,PPARG,CST3,PTGS1,UGT2B7,CFH,TP53,ABCB1,HP,NPHS1,APOA1,ADRA1B,AHSG,CYP2C19,APOC3,PLA2G2A,ITGA2,CYP2C9,POMC,KLK3,ABCC3,GLO1,ABCC2,ALB,APOE,PPARA,SAA1,ATM,GSN,TTR
235	Hyperbilirubinemia	C0020433	12	99	5.68858660177e-09	4.740770627395602e-05	F7,UGT1A6,UGT1A1,SLC25A13,UGT1A,ABCB1,UGT1A8,UGT1A7,ABCC3,ABCC2,UGT1A10,UGT1A9
237	Palmar hyperkeratosis	C0240641	7	28	8.54920068072e-09	4.781117611458543e-05	KRT16,KRT9,KRT14,KRT10,KRT6A,KRT1,KRT5
238	Epidermolysis bullosa simplex, Cockayne-Touraine type	C0079298	7	28	8.54920068072e-09	4.801291103490014e-05	KRT9,GFAP,KRT14,KRT10,KRT1,KRT5,FN1
239	Acute Coronary Syndrome	C0948089	21	320	9.79998793227e-09	4.8214645955214844e-05	PTGS2,F7,PPARG,CST3,PTGS1,UGT2B7,CARM1,ABCB1,SLCO1A2,APOA1,PPBP,CYP2C19,APOC3,PLA2G2A,ITGA2,CYP2C9,ALB,APOE,PPARA,ATM,GSN
241	Hepatitis D Infection	C0011226	9	55	1.34290430998e-08	4.861811579584426e-05	UGT1A6,UGT1A1,PRSS3,UGT1A,UGT1A8,SLC10A1,UGT1A7,UGT1A10,UGT1A9
242	Abnormality of the plantar skin of foot	C4020946	9	57	1.92223106321e-08	4.881985071615897e-05	KRT16,KRT9,TBL1XR1,KRT14,KRT10,KRT6A,KRT1,KRT5,SIN3A
246	Hypertriglyceridemia result	C1522137	8	44	2.42297577557e-08	4.962679039741779e-05	PPARG,APOA4,APOC2,APOA1,APOC3,APOE,PPARA,APOA2
247	Plantar hyperkeratosis	C1856954	7	32	2.71539660757e-08	4.98285253177325e-05	KRT16,KRT9,KRT14,KRT10,KRT6A,KRT1,KRT5
248	Influenza	C0021400	26	497	3.08238220503e-08	5.003026023804721e-05	ST13,PTGS2,PPARG,UGT1A6,PTGS1,SERPING1,UGT1A1,SETX,CFH,MED1,UGT1A,NLRC4,SLC22A8,TP53,ABCB1,HP,UGT1A8,PPBP,UGT1A7,GRAP2,ALB,SLA2,KRT5,UGT1A10,UGT1A9,TTR
250	Drug Allergy	C0013182	10	79	4.56301337826e-08	5.0433730078676615e-05	PTGS1,UGT1A1,UGT2B7,ABCB1,UGT1A8,CYP2C19,CYP2C9,UGT1A7,ABCC2,UGT1A9
251	Dermal atrophy	C0151514	17	237	4.84983907478e-08	5.0635464998991324e-05	PTGS2,UGT1A6,PTGS1,APOC1,SETX,CFH,TP53,KRT14,ABCC6,CYP2C9,POMC,TTN,KLK3,APOE,KRT5,ABCC11,CRB1
252	Coronary heart disease 7	C0010054	33	754	4.92759463233e-08	5.083719991930603e-05	PTGS2,F7,PPARG,UGT1A6,CST3,PTGS1,UGT1A1,APOA4,APOC1,CFH,CES1,TP53,ABCB1,HP,APOA1,AHSG,ABCC6,CYP2C19,APOC3,PLA2G2A,SCN5A,ITGA2,CYP2C9,TTN,GLO1,ALB,APOE,PPARA,SAA1,FN1,PF4V1,APOA2,ATM
253	Kidney Diseases	C0022658	33	755	5.08740902738e-08	5.1038934839620735e-05	PTGS2,F7,PPARG,CST3,APOA4,CFH,SLC22A8,TP53,ABCB1,CTSL,HP,NPHS1,APOA1,ADRA1B,AHSG,APOC3,CYP2C9,POMC,ABCC3,ABCC4,ABCC2,ALB,APOE,PPARA,ANXA1,SAA1,FN1,RYR2,ABCC11,SLC22A6,ATM,GSN,TTR
256	Acute myocardial ischemia	C0151744	25	484	6.96247038912e-08	5.164413960056486e-05	F7,PPARG,UGT1A6,UGT1A1,APOA4,CFH,DMD,PDE4B,ABCB1,APOA1,ABCC6,CYP2C19,APOC3,PLA2G2A,SCN5A,ITGA2,CYP2C9,POMC,TTN,ALB,RLN3,APOE,PPARA,RYR2,ATM
257	Anemia, Sickle Cell	C0002895	18	271	7.34913397915e-08	5.1845874520879563e-05	F7,UGT1A6,UGT1A1,UGT2B7,UGT1A,HP,UGT1A8,APOA1,PPBP,CYP2C19,ITGA2,HPX,CYP2C9,UGT1A7,APOE,FN1,UGT1A10,UGT1A9
258	Leukopenia	C0023530	19	301	8.04740104554e-08	5.204760944119427e-05	UGT1A6,UGT1A1,UGT2B7,CFH,CES1,PALB2,UGT1A,TP53,PDE4B,ABCB1,UGT1A8,ABCC1,UGT1A7,ABCC3,ABCC4,ABCC2,ABCC11,UGT1A9,ATM
260	Plaque, Atherosclerotic	C0011389	16	226	1.31369395917e-07	5.245107928182369e-05	PTGS2,PPARG,CST3,APP,SERPING1,APOA4,GFAP,APOA1,ABCC4,ALB,APOE,SAA1,GNAI1,ABCC11,GSN,TTR
261	Drug Resistant Epilepsy	C1096063	8	53	1.3323636594e-07	5.265281420213839e-05	GFAP,ABCB1,CYP2C19,ABCC1,POMC,ABCC2,ALB,APOE
262	Febrile Neutropenia	C0746883	6	27	1.56479219027e-07	5.28545491224531e-05	UGT1A6,UGT1A1,UGT1A,TP53,ABCB1,UGT1A7
264	Inflammation	C0021368	29	647	1.7184083223e-07	5.3258018963082505e-05	PTGS2,F7,PPARG,CST3,APP,PTGS1,SERPING1,UGT1A1,PRSS3,APOA4,CXCL6,APOC1,CFH,TP53,ABCB1,HP,APOA1,AHSG,ABCC6,CYP2C19,APOC3,POMC,APOE,PPARA,ANXA1,SAA1,PTGDR2,FN1,APOA2
265	Vascular Diseases	C0042373	22	410	1.87010402275e-07	5.3459753883397214e-05	PTGS2,F7,PPARG,CST3,APP,DMD,TP53,HP,APOA1,AHSG,ABCC6,APOC3,PLA2G2A,ITGA2,CYP2C9,GLO1,ABCC4,ALB,APOE,PF4V1,ATM,TTR
267	Hypercholesterolemia, autosomal dominant, type B	C0020443	15	212	2.9399925261e-07	5.386322372402663e-05	PPARG,UGT1A1,APOA4,CES1,SLC25A13,ABCB1,APOA1,CYP2C19,APOC3,PLA2G2A,CYP2C9,ALB,APOE,PPARA,APOA2
269	Hyperlipoproteinemia	C0020476	7	43	3.20938162379e-07	5.426669356465604e-05	APOC2,APOA1,APOC3,ALB,APOE,PPARA,APOA2
275	Restenosis	C0333186	15	220	4.84544875334e-07	5.547710308654428e-05	F7,PPARG,SERPING1,APOA4,TP53,HP,CYP2C19,APOC3,PLA2G2A,ITGA2,ALB,APOE,ANXA1,ABCC11,ATM
276	Neoplasm of the liver	C0023903	44	1290	5.82896041545e-07	5.5678838006858985e-05	ST13,PTGS2,F7,PPARG,UGT1A6,APP,SERPING1,UGT1A1,DCD,APOA4,TIAM1,SLC25A13,UGT1A,LPCAT1,TP53,ABCB1,APOC2,HP,APOA1,AHSG,HDAC3,CYP2C19,APOC3,PLA2G2A,SLC10A1,ABCC1,HPX,CYP2C9,UGT1A7,GRAP2,ABCC3,ITIH1,ABCC2,ALB,DERL1,APOE,PPARA,KRT5,ANXA1,FN1,BBC3,SLC1A5,ATM,TTR
279	Insulin resistance syndrome	C3714619	7	48	7.79485281988e-07	5.6284042767803105e-05	PPARG,APOA4,APOC1,APOC2,ALB,PPARA,APOA2
280	Myofibrillar myopathy, BAG3-related	C2678065	6	34	8.61470715208e-07	5.6485777688117814e-05	CFH,DMD,TTN,FN1,LDB3,GSN
286	Coronary Restenosis	C0948480	7	49	9.18830170837e-07	5.7696187210006054e-05	F7,PPARG,TP53,ABCB1,CYP2C19,APOE,PPARA
287	Cerebral Amyloid Angiopathy	C0085220	7	50	1.07887487255e-06	5.789792213032076e-05	CST3,APP,ABCB1,APOA1,APOE,GSN,TTR
290	Palmoplantar keratoderma, nonepidermolytic, focal	C0022596	12	156	1.25985319432e-06	5.8503126891264876e-05	KRT16,KRT9,KRT6B,DMD,KRT14,KRT10,KRT6A,SCN5A,TTN,KRT1,KRT5,LDB3
291	Hepatic steatosis	C0015695	21	427	1.43202914538e-06	5.8704861811579585e-05	PTGS2,PPARG,UGT1A1,TBL1XR1,APOC1,TBL1X,SLC25A13,HP,APOA1,AHSG,CYP2C19,APOC3,POMC,ABCC3,ABCC2,ALB,APOE,PPARA,SAA1,GNAI2,NCOA3
292	Carotid Atherosclerosis	C0577631	10	111	1.52012801624e-06	5.8906596731894294e-05	F7,PPARG,APOA4,TP53,HP,APOA1,APOC3,PLA2G2A,ITGA2,APOE
295	Nausea	C0027497	7	54	1.97885380138e-06	5.9511801492838413e-05	UGT2B7,TP53,ABCB1,CYP2C19,CYP2C9,POMC,SAA1
296	body mass	C0518010	9	94	2.3818784618e-06	5.9713536413153116e-05	F7,PPARG,APOA4,APOA1,APOC3,POMC,APOE,PMCH,APOA2
297	Bleeding with minor or no trauma	C0019080	8	74	2.48041263251e-06	5.9915271333467824e-05	F7,PTGS1,CYP2C19,ITGA2,CYP2C9,POMC,APOE,KRT1
300	Chronic kidney disease	C1561643	18	342	2.52399932021e-06	6.0520476094411944e-05	PPARG,CST3,PTGS1,TOMM40,APOA4,CFH,TP53,ABCB1,HP,AHSG,CYP2C19,ITGA2,ALB,APOE,SAA1,PTGDR2,FN1,ATM
301	Mild cognitive impairment	C1270972	11	141	2.58780934181e-06	6.0722211014726647e-05	CST3,APP,TOMM40,GFAP,DMD,TP53,KRT14,APOC2,APOE,SAA1,TTR
302	Malignant neoplasm of adrenal cortex	C0346402	5	26	2.62133758355e-06	6.0923945935041355e-05	TP53,ABCB1,POMC,ALB,KRT5
303	Hyperlipidemia, familial combined	C0020474	9	95	2.62511790305e-06	6.112568085535607e-05	PPARG,APOA4,APOA1,APOC3,ALB,APOE,PPARA,FN1,APOA2
304	Oral leukoplakia	C0023532	8	75	2.7797938561e-06	6.132741577567077e-05	PTGS2,KRT16,KRT6B,TP53,KRT14,KRT6A,KRT5,ATM
305	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	C0030286	7	57	3.01572635697e-06	6.152915069598548e-05	SLC25A13,TP53,ABCC1,UGT1A7,POMC,ABCC2,ALB
306	Cardiovascular Diseases	C0007222	36	1029	3.14761176612e-06	6.173088561630019e-05	PTGS2,F7,PPARG,CST3,APP,PTGS1,TOMM40,UGT1A1,APOA4,APOC1,CFH,UGT1A,TP53,ABCB1,APOC2,HP,APOA1,AHSG,PPBP,ABCC6,HDAC3,CYP2C19,APOC3,PLA2G2A,SCN5A,ITGA2,CYP2C9,ALB,APOE,PPARA,KRT5,ANXA1,SAA1,FN1,RYR2,ATM
309	Dyslipidemias	C0242339	14	228	3.82857755321e-06	6.23360903772443e-05	PTGS2,F7,PPARG,KRT16,ABCB1,APOC2,HP,APOA1,AHSG,ABCC6,APOC3,POMC,APOE,PPARA
310	Obesity, Visceral	C2936179	6	42	3.87515350642e-06	6.253782529755901e-05	F7,TP53,APOC3,POMC,PPARA,APOA2
320	Hyperkeratosis	C0870082	15	258	3.9169309709e-06	6.455517450070606e-05	KRT16,KRT9,KRT6B,APOC1,DMD,KRT13,TP53,KRT14,KRT10,KRT6A,SCN5A,TTN,KRT1,KRT5,LDB3
321	Metabolic Syndrome X	C0524620	26	638	4.01584730525e-06	6.475690942102078e-05	PTGS2,PPARG,KRT16,APP,PTGS1,TOMM40,UGT1A1,TBL1XR1,APOA4,APOC1,GNAT3,TBL1X,APOC2,APOA1,AHSG,ABCC6,HDAC3,APOC3,POMC,GLO1,ALB,APOE,PPARA,APOA2,GNAI2,NCOA3
323	Memory Loss	C0002622	7	61	5.08687332024e-06	6.51603792616502e-05	CST3,APP,GNAI3,ABCB1,POMC,APOE,GNAI1
324	Stomach Diseases	C0038354	6	44	5.35694806192e-06	6.53621141819649e-05	PTGS2,PTGS1,TP53,CYP2C19,CYP2C9,ANXA1
325	Cognition Disorders	C0009241	7	62	5.76078685455e-06	6.556384910227961e-05	PTGS2,CST3,SPAST,APP,APOC1,MED13L,APOE
326	Renal Insufficiency, Chronic	C0035078	18	363	5.9694206358e-06	6.576558402259431e-05	PPARG,CST3,APP,CFH,SLC22A11,TP53,ABCB1,HP,NPHS1,CYP2C19,PLA2G2A,KLK3,ABCC4,ABCC2,ALB,APOE,SLC22A6,ATM
327	Hyperhidrosis	C0020458	9	104	5.97918546763e-06	6.596731894290902e-05	PPARG,KRT16,KRT9,KRT6B,NLRC4,KRT14,KRT6A,KRT1,KRT5
328	Acute myocardial infarction	C0155626	14	237	6.12975698688e-06	6.616905386322372e-05	PTGS2,F7,PPARG,CST3,DMD,ABCB1,HP,APOA1,ABCC6,CYP2C19,PLA2G2A,SCN5A,ITGA2,APOE
329	Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis	C0033687	13	209	6.53367377745e-06	6.637078878353843e-05	PTGS2,CFH,CTSL,HP,NPHS1,APOA1,CYP2C9,POMC,ALB,APOE,PPARA,SAA1,FN1
330	Diabetes mellitus type 2	C0011860	56	1972	6.66794580872e-06	6.657252370385314e-05	ST13,PTGS2,F7,PPARG,PEG3,KRT16,CST3,TOMM40,UGT1A1,DCD,APOA4,THRAP3,APOC1,CFH,CES1,DMD,FABP6,UGT1A,DGKG,TP53,ABCB1,SLCO1A2,CTSL,APOC2,HP,NPHS1,APOA1,AHSG,ABCC6,CYP2C19,APOC3,PLA2G2A,SCN5A,ITGA2,HPX,CYP2C9,TSC22D1,POMC,GRAP2,DICER1,GLO1,ABCC2,ALB,APOE,PPARA,ANXA1,CAMTA1,FN1,ABCC11,APOA2,GNAI2,CFB,CRB1,ATM,GSN,TTR
333	Liver Diseases	C0023895	24	586	7.99293880371e-06	6.717772846479727e-05	PTGS2,F7,PPARG,CST3,UGT1A1,CFH,CES1,SLC25A13,TP53,ABCB1,APOA1,CYP2C19,APOC3,LAT,CYP2C9,ABCC3,ABCC2,ALB,APOE,ANXA1,FN1,PMCH,GNAI2,ATM
335	Hypothyroidism	C0020676	17	341	9.33915227286e-06	6.758119830542666e-05	F7,NCOR1,APP,SACS,ABCB1,NPHS1,ABCC6,APOC3,KRT6A,POMC,NCOR2,APOE,ANXA1,SAA1,NCOA3,GSN,TTR
336	Epidermal thickening	C0494876	16	309	9.65462563229e-06	6.778293322574138e-05	PPARG,KRT16,KRT9,KRT6B,DMD,KRT13,CHKB,KRT14,KRT10,KRT6A,SCN5A,POMC,TTN,KRT1,KRT5,LDB3
337	Autosomal dominant non-syndromic sensorineural deafness type DFNA	C0443147	40	1262	1.07064131442e-05	6.798466814605608e-05	AP4E1,PPARG,GJC2,KRT16,CST3,KRT9,SPAST,APP,KRT6B,SERPING1,TBL1XR1,GFAP,GNAI3,SETX,CFH,KRT13,NLRC4,TP53,KRT14,KRT10,APOA1,ABCC6,SCN5A,MED13L,ITGA2,CYP2C9,TTN,DICER1,APOE,KRT1,KRT5,CAMTA1,FN1,KCNMA1,PLAG1,RYR2,GNAI2,LDB3,GSN,TTR
338	Abnormality of the level of lipoprotein cholesterol	C4023615	5	33	1.14859253819e-05	6.81864030663708e-05	PPARG,SLC25A13,APOA1,APOC3,APOE
339	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	C0031117	28	756	1.15730999245e-05	6.83881379866855e-05	PPARG,GJC2,SPAST,APP,PTGS1,SERPING1,GFAP,UGT2B7,SETX,CES1,SACS,MED25,NLRC4,SLC22A8,TP53,ABCB1,TLN2,ABCC6,ABCC1,ABCC3,ABCC4,ABCC2,APOE,MED9,LDB3,ATM,GSN,TTR
344	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	C0740394	7	69	1.29410190876e-05	6.939681258825903e-05	PPARG,APOA4,SLC22A11,APOA1,APOC3,APOE,SAA1
345	Familial type 3 hyperlipoproteinemia	C0020479	5	34	1.3762597055e-05	6.959854750857374e-05	APOC1,APOC2,APOA1,APOC3,APOE
346	Aural atresia, congenital	C1842937	6	51	1.47191267316e-05	6.980028242888844e-05	CST3,APP,APOE,PPARA,GSN,TTR
362	Papilloma	C0030354	12	196	1.54649179086e-05	7.302804115392375e-05	PTGS2,PPARG,PEG3,KRT16,KRT9,TP53,KRT14,APOE,KRT1,KRT5,ABCC11,TTR
363	Hyperthyroidism	C0020550	10	141	1.54946296574e-05	7.322977607423844e-05	PPARG,APP,UGT1A1,ABCB1,CTSL,APOA1,APOC3,ANXA1,FN1,APOA2
366	Obesity	C0028754	59	2181	1.66387824145e-05	7.383498083518258e-05	ST13,PTGS2,F7,CFD,PPARG,UGT1A6,PEG3,KRT16,CST3,CROT,APP,UGT1A1,TBL1XR1,APOA4,UGT2B7,THRAP3,APOC1,CFH,TIAM1,CES1,GNAT3,FABP6,UGT1A,DGKG,TP53,ABCB1,CTSL,HP,UGT1A8,APOA1,ADRA1B,AHSG,CYP2C19,APOC3,CYP2C9,UGT1A7,POMC,GRAP2,DICER1,GLO1,ABCC2,ALB,NCOR2,APOE,PPARA,SAA1,FN1,KCNMA1,PMCH,SIN3A,ABCC11,APOA2,UGT1A10,GNAI2,UGT1A9,NCOA3,CFB,CRB1,ATM
367	Thromboembolism	C0040038	9	118	1.83622894184e-05	7.403671575549728e-05	PTGS2,F7,APOA4,CFH,CYP2C19,PLA2G2A,ITGA2,CYP2C9,ATM
370	Neoplasm of the colon	C0009375	29	817	1.87414819645e-05	7.46419205164414e-05	PTGS2,PPARG,UGT1A6,APP,PTGS1,UGT1A1,CFH,TIAM1,UGT1A,CHKB,TP53,AMPD3,ABCB1,HDAC3,PLA2G2A,ITGA2,ABCC1,CYP2C9,POMC,GRAP2,ABCC4,CABLES1,ABCC2,APOE,SAA1,FN1,UGT1A9,NCOA3,ATM
371	Cerebral palsy, spastic quadriplegic, 3	C0007789	8	95	1.97093038803e-05	7.48436554367561e-05	PTGS2,F7,AP4E1,UGT1A1,CTSL,POMC,APOE,TTR
372	Hypertriglyceridemia	C0020557	9	119	1.97692100466e-05	7.50453903570708e-05	PPARG,APOA4,SLC25A13,APOC2,APOA1,APOC3,APOE,PPARA,APOA2
373	Primary biliary cirrhosis	C0008312	14	263	2.11114125885e-05	7.524712527738552e-05	PTGS2,PPARG,APP,TP53,ABCB1,ABCC6,SLC10A1,ABCC1,ABCC3,ABCC4,ABCC2,ALB,APOE,ATM
374	Abnormal blistering of the skin	C2132198	7	74	2.17802498831e-05	7.544886019770022e-05	KRT16,KRT6B,KRT14,KRT10,KRT6A,KRT1,KRT5
375	Acute postoperative pain	C0030201	5	37	2.28582472408e-05	7.565059511801494e-05	PTGS2,UGT2B7,ABCB1,POMC,KLK3
376	Ischemic stroke	C0948008	18	401	2.40320998147e-05	7.585233003832964e-05	PTGS2,F7,PPARG,PTGS1,CFH,TP53,ABCB1,APOA1,AHSG,ABCC6,CYP2C19,APOC3,PLA2G2A,ITGA2,CYP2C9,APOE,PPARA,ATM
377	Complications of Diabetes Mellitus	C0342257	7	75	2.4048968404e-05	7.605406495864434e-05	PTGS2,F7,PPARG,HP,CYP2C19,ALB,APOE
380	Erythema	C0041834	9	123	2.63628306674e-05	7.665926971958846e-05	PTGS2,KRT16,KRT9,SERPING1,NLRC4,TP53,KRT10,KRT1,KRT5
381	Peptic ulcer	C0030920	9	123	2.63628306674e-05	7.686100463990318e-05	PTGS2,PPARG,UGT1A6,PTGS1,TP53,ABCB1,CYP2C19,ABCC1,CYP2C9
385	SUDDEN INFANT DEATH SYNDROME	C0038644	8	99	2.74727775994e-05	7.766794432116198e-05	CTSL,CYP2C19,SCN5A,CYP2C9,POMC,APOE,RYR2,ATM
386	Alzheimer Disease, Late Onset	C0494463	7	77	2.91836562458e-05	7.78696792414767e-05	CST3,APP,TOMM40,GFAP,APOC1,APOC2,APOE
387	Thickened skin	C0241165	16	339	3.16294914987e-05	7.80714141617914e-05	PPARG,KRT16,KRT9,KRT6B,DMD,KRT13,CHKB,KRT14,KRT10,KRT6A,SCN5A,POMC,TTN,KRT1,KRT5,LDB3
389	Dermatosis NOS	C0037274	20	483	3.22639720917e-05	7.847488400242082e-05	PTGS2,F7,PPARG,KRT9,PTGS1,UGT1A1,DCD,GFAP,CFH,TP53,PDE4B,KRT14,KRT10,ABCC6,KRT6A,POMC,GRAP2,PPARA,KRT1,KRT5
390	Neurotoxicity Syndromes	C0235032	5	40	3.62636624008e-05	7.867661892273554e-05	ABCB1,ADRA1B,CYP2C19,LAT,CYP2C9
391	Myocardial Infarction	C0027051	33	1019	3.69637989327e-05	7.887835384305022e-05	PTGS2,F7,CDCP1,PPARG,KRT16,CST3,PTGS1,SERPING1,UGT1A1,APOA4,CXCL6,GFAP,APOC1,CFH,TP53,ABCB1,HP,APOA1,AHSG,ABCC6,CYP2C19,APOC3,PLA2G2A,SCN5A,ITGA2,CYP2C9,APOE,PPARA,FN1,KCNMA1,APOA2,ATM,GSN
392	Cystic Fibrosis	C0010674	19	451	3.76773093803e-05	7.908008876336494e-05	PTGS2,PPARG,PTGS1,UGT1A1,CXCL6,DMD,LPCAT1,SACS,ABCB1,HP,CYP2C19,PLA2G2A,ABCC1,GRAP2,PPARA,ANXA1,PF4V1,ABCC11,SLC1A5
393	Diarrhea 8, secretory sodium, congenital	C0011991	17	379	3.80310564101e-05	7.928182368367964e-05	PTGS2,SERPING1,UGT1A1,UGT2B7,CFH,CES1,ABCB1,UGT1A8,CYP2C19,SCN5A,CYP2C9,UGT1A7,ABCC2,APOE,SAA1,UGT1A9,TTR
399	Brain Ischemia	C0007786	18	415	3.83058292136e-05	8.049223320556788e-05	PTGS2,F7,PPARG,PTGS1,UGT1A1,GFAP,TP53,CTSL,SCN5A,ITGA2,ALB,APOE,PPARA,KRT5,ANXA1,BBC3,ATM,TTR
400	Azorean disease	C0024408	7	80	3.85847560656e-05	8.069396812588258e-05	CST3,GFAP,TP53,APOE,BBC3,ATM,TTR
402	Chromosome 11p deletion syndrome	C0812435	4	25	3.90831360679e-05	8.1097437966512e-05	SLC22A8,ABCC4,ABCC2,SLC22A6
403	Drug Eruptions	C0011609	4	25	3.90831360679e-05	8.129917288682672e-05	APOC2,APOA1,APOC3,TTR
404	Amyloidosis	C0002726	9	129	3.9748051288e-05	8.150090780714142e-05	CST3,APP,HP,APOA1,APOE,SAA1,APOA2,GSN,TTR
405	Ischemia	C0022116	24	647	4.14773014912e-05	8.170264272745613e-05	PTGS2,F7,PPARG,APP,GFAP,DMD,TP53,APOC3,PLA2G2A,SCN5A,CYP2C9,POMC,TTN,GRAP2,GLO1,ALB,APOE,PPARA,ANXA1,FN1,KCNMA1,SLC1A5,ATM,TTR
406	Coronary artery stenosis	C0242231	7	81	4.22309625429e-05	8.190437764777082e-05	F7,PPARG,HP,CYP2C19,PLA2G2A,APOE,PPARA
407	Chronic Kidney Insufficiency	C0403447	11	186	4.29023867108e-05	8.210611256808554e-05	PPARG,CST3,APOA4,TP53,ABCB1,HP,AHSG,CYP2C19,ALB,APOE,ATM
408	Intrahepatic cholestasis	C0008372	6	60	4.34695353739e-05	8.230784748840024e-05	SLC25A13,SLC10A1,ABCC3,ABCC4,ABCC2,APOE
409	Heart Diseases	C0018799	17	386	4.81936326345e-05	8.250958240871496e-05	PPARG,DMD,ABCB1,HDAC3,APOC3,PLA2G2A,SCN5A,ABCC1,CYP2C9,TTN,ABCC2,ALB,APOE,PPARA,PF4V1,RYR2,TTR
410	Dementia, Vascular	C0011269	7	83	5.03895528028e-05	8.271131732902966e-05	CST3,APP,TP53,PLA2G2A,ALB,APOE,FN1
415	Membranous nephropathy, susceptibility to	C0017665	7	84	5.49366677336e-05	8.371999193060318e-05	CFH,NPHS1,APOA1,PLA2G2A,ALB,APOE,FN1
416	Steatohepatitis	C2711227	12	222	5.67567575283e-05	8.39217268509179e-05	PPARG,TBL1XR1,APOC1,TBL1X,SLC25A13,APOA1,AHSG,APOC3,APOE,PPARA,GNAI2,NCOA3
417	Memory impairment	C0233794	13	255	5.97869659468e-05	8.41234617712326e-05	PPARG,SPAST,APP,PTGS1,UGT1A1,GABBR1,GFAP,APOC1,APOA1,POMC,APOE,ANXA1,CAMTA1
418	Neutropenia	C0027947	13	255	5.97869659468e-05	8.432519669154732e-05	UGT1A1,CFH,CES1,UGT1A,TP53,PDE4B,ABCB1,CYP2C19,ABCC1,CYP2C9,UGT1A7,ABCC2,UGT1A9
419	Microsatellite Instability	C0796369	6	63	5.97986954153e-05	8.452693161186202e-05	PPARG,UGT1A6,TP53,CYP2C9,POMC,APOE
420	Nephrotic Syndrome, Minimal Change	C1704321	5	44	6.32381979224e-05	8.472866653217672e-05	ABCB1,NPHS1,HPX,ALB,APOE
421	Familial adenomatous polyposis 1	C0032580	17	395	6.47595509279e-05	8.493040145249142e-05	PTGS2,PPARG,UGT1A6,PTGS1,UGT1A1,UGT2B7,TP53,ABCB1,APOC2,APOA1,PLA2G2A,KLK3,MED15,UGT1A10,ATM,GSN,TTR
422	Hippocampal sclerosis	C1504404	5	45	7.20043177085e-05	8.513213637280614e-05	GABBR1,GFAP,ABCB1,ABCC1,APOE
423	Drug usage	C0242510	5	45	7.20043177085e-05	8.533387129312084e-05	PTGS2,TP53,ABCB1,CYP2C9,APOE
426	Cholestasis, benign recurrent intrahepatic 1	C0008370	15	328	7.44730156552e-05	8.593907605406496e-05	PPARG,UGT1A1,SLC25A13,ABCB1,HP,APOA1,APOC3,PLA2G2A,SLC10A1,POMC,ABCC3,ABCC4,ABCC2,PPARA,SAA1
439	Diabetic Angiopathies	C0011875	7	88	7.6685962747e-05	8.856163001815614e-05	F7,PPARG,APOA4,HP,ALB,APOE,FN1
440	Unspecified visual loss	C3665346	6	66	8.08304873161e-05	8.876336493847086e-05	CFH,ABCC6,ANXA1,CFB,CRB1,TTR
441	cardiac event	C0741923	5	46	8.1712697706e-05	8.896509985878556e-05	ABCB1,HP,CYP2C19,SCN5A,RYR2
442	Skin Diseases, Genetic	C0037277	5	46	8.1712697706e-05	8.916683477910026e-05	KRT9,KRT14,KRT10,KRT1,KRT5
443	Old myocardial infarction	C0155668	4	29	8.29395814739e-05	8.936856969941496e-05	APOA4,APOA1,CYP2C9,APOE
444	Pituitary dependent hypercortisolism	C0221406	4	29	8.29395814739e-05	8.957030461972968e-05	PPARG,POMC,KLK3,GNAI2
445	Nephrotic syndrome, type 5, with or without ocular abnormalities	C0027726	13	263	8.3190794635e-05	8.977203954004438e-05	PTGS2,APOA4,ABCB1,CTSL,NPHS1,APOA1,HPX,GLO1,ALB,APOE,SAA1,FN1,GSN
